Global Anti-obesity Drugs Market Growth 2025-2031
Description
The global Anti-obesity Drugs market size is predicted to grow from US$ 73050 million in 2025 to US$ 92120 million in 2031; it is expected to grow at a CAGR of 3.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
LP Information, Inc. (LPI) ' newest research report, the “Anti-obesity Drugs Industry Forecast” looks at past sales and reviews total world Anti-obesity Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-obesity Drugs sales for 2025 through 2031. With Anti-obesity Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-obesity Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-obesity Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-obesity Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-obesity Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-obesity Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-obesity Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-obesity Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segmentation by Application:
Kids
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-obesity Drugs market?
What factors are driving Anti-obesity Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-obesity Drugs market opportunities vary by end market size?
How does Anti-obesity Drugs break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
The report analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 41.45 percent over the period 2013-2022.
LP Information, Inc. (LPI) ' newest research report, the “Anti-obesity Drugs Industry Forecast” looks at past sales and reviews total world Anti-obesity Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-obesity Drugs sales for 2025 through 2031. With Anti-obesity Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-obesity Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-obesity Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-obesity Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-obesity Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-obesity Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-obesity Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-obesity Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segmentation by Application:
Kids
Adults
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-obesity Drugs market?
What factors are driving Anti-obesity Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-obesity Drugs market opportunities vary by end market size?
How does Anti-obesity Drugs break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
107 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Anti-obesity Drugs by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Anti-obesity Drugs by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
